Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 20 Pancreatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 17 Ovarian Neoplasms 16 Fallopian Tube Neoplasms 12 Triple Negative Breast Neoplasms 10 Neoplasm Metastasis 10 Carcinoma, Ovarian Epithelial 10 Unspecified Adult Solid Tumor, Protocol Specific 8 Neoplasms 7 Lung Neoplasms 7 Endometrial Neoplasms 7 Esophageal Neoplasms 6 Brenner Tumor 6 Breast Neoplasms, Male 6 Stomach Neoplasms 5 Melanoma 5 Squamous Cell Carcinoma of Head and Neck 4 Peritoneal Neoplasms 3 Gallbladder Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma of Lung 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2

Interventions

Sorafenib 20 Bevacizumab 7 pembrolizumab 5 Oxaliplatin 5 Melphalan 5 Leucovorin 5 Irinotecan 5 Nivolumab 4 Ipilimumab 4 Fluorouracil 4 Cyclophosphamide 4 Capecitabine 4 fludarabine 3 Sirolimus 3 Radiosurgery 3 Gemcitabine 3 Filgrastim 3 Carboplatin 3 toripalimab 2 spartalizumab 2 regorafenib 2 pazopanib 2 lenvatinib 2 ixabepilone 2 durvalumab 2 atezolizumab 2 Vorinostat 2 Thiotepa 2 Temozolomide 2 Sirtuins 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Liver Neoplasms × Taxes × Clear all

NCT00732836 2016-02-05

Hepatic Arterial Infusion (HAI) of Abraxane

M.D. Anderson Cancer Center

Phase 1 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡